Bendamustine can severely impair T-cell immunity against cytomegalovirus.
Toru
T
Hosoda
Akihiro
A
Yokoyama
Mie
M
Yoneda
Ryusuke
R
Yamamoto
Kota
K
Ohashi
Toshiya
T
Kagoo
Hironori
H
Ueno
Saigen
S
Boku
Takahiro
T
Yano
D000369:Aged, 80 and over; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects* / Q000627:therapeutic use; D000069461:Bendamustine Hydrochloride; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000276:immunology*; D005260:Female; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology*
D018906:Antineoplastic Agents, Alkylating; D009588:Nitrogen Mustard Compounds; D000069461:Bendamustine Hydrochloride